Format

Send to

Choose Destination
Biochim Biophys Acta. 2006 Nov-Dec;1762(11-12):1013-24. Epub 2006 Apr 21.

Transgenic mouse models of amyotrophic lateral sclerosis.

Author information

1
Research Centre of CHUL, Department of Anatomy and Physiology of Laval University, 2705 Boulevard Laurier, Quebec, QC, Canada G1V 4G2. jean-pierre.julien@crchul.ulaval.ca

Abstract

The discovery of missense mutations in the gene coding for the Cu/Zn superoxide dismutase 1 (SOD1) in subsets of familial cases was rapidly followed by the generation of transgenic mice expressing various forms of SOD1 mutants. The mice overexpressing high levels of mutant SOD1 mRNAs do develop motor neuron disease but unraveling the mechanisms of pathogenesis has been very challenging. Studies with mouse lines suggest that the toxicity of mutant SOD1 is unrelated to copper-mediated catalysis but rather to propensity of a subfraction of mutant SOD1 proteins to form misfolded protein species and aggregates. However, the mechanism of toxicity of SOD1 mutants remains to be elucidated. Involvement of cytoskeletal components in ALS pathogenesis is supported by several mouse models of motor neuron disease with neurofilament abnormalities and with genetic defects in microtubule-based transport. Here, we describe how transgenic mouse models have been used for understanding pathogenic pathways of motor neuron disease and for pre-clinical drug testing.

PMID:
16675207
DOI:
10.1016/j.bbadis.2006.03.006
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center